Showing results (21-30 of 1,038) with videos related to
Sort By:
Pageof 104
Japanese Journal of Cancer Research : Gann|May 1, 1992
Mouse-human chimeric antibody MH171 against the multidrug transporter P-glycoproteinK Ariyoshi, H Hamada, M Naito, et al.Proceedings of the National Academy of Sciences of the United States of America|November 1, 1987
Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissuesF Thiebaut, T Tsuruo, H Hamada, et al.Cancer Research|June 1, 1993
Molecular cloning and characterization of the complementary DNA for the M(r) 85,000 protein overexpressed in adriamycin-resistant human tumor cellsY Sugimoto, H Hamada, S Tsukahara, et al.Cancer Research|April 1, 1988
Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16I Sugawara, I Kataoka, Y Morishita, et al.Japanese Journal of Cancer Research : Gann|June 1, 1992
Effector cell analysis of human multidrug-resistant cell killing by mouse-human chimeric antibody against P-glycoproteinY Nishioka, S Sone, Y Heike, et al.The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|February 1, 1989
Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle proteinF Thiebaut, T Tsuruo, H Hamada, et al.Cancer Research|December 15, 1988
Mr 85,000 membrane protein specifically expressed in adriamycin-resistant human tumor cellsH Hamada, E Okochi, M Watanabe, et al.Japanese Journal of Cancer Research : Gann|November 1, 1989
A novel multidrug resistance in cultured leukemia and lymphoma cells detected by a monoclonal antibody to 85-kDa protein, MRK20T Ohtsu, Y Ishida, K Tobinai, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1987
[Antitumor drug screening at the National Cancer Institute, U.S.A]T TsuruoGan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1994
[MDR reversing drugs for clinical development]T TsuruoPageof 104